| generic name | brand name | drug class or drug category | general use |
| alprazolam | Xanax | benzodiazepine; antianxiety | anxiety and panic disorder |
| butorphanol | Stadol | narcotic analgesic | this drug is used in the nose to relieve pain and headaches |
| clonazepam | Klonopin | benzodiazepine | to treat seizures and panic disorder; anxiety |
| diazepam | Valium | benzodiazepine | anxiety; agitation; seizures; muscle spasms |
| eszopiclone | Lunesta | sedative hypnotic | to induce sleep; to treat insomnia |
| lorazepam | Ativan | benzodiazepine; antianxiety | anxiety disorders |
| modafinil | Provigil | wakefulness-promoting agent | excessive sleepiness; narcolepsy; shift work sleep disorder |
| phentermine | Adipex P | appetite suppressant | obesity; to lose weight |
| temazepam | Restoril | benzodiazepine; sedative hypnotic | to induce sleep; to treat insomnia |
| zaleplon | Sonata | sedative hypnotic | to induce sleep; to treat insomnia |
| zolpidem | Ambien | sedative-hypnotic | to induce sleep; to treat insomnia |
|
Schedule IV same as C-IV --- substances in this schedule have a low potential for abuse relative to substances in schedule III. --- a prescription for a Schedule IV drug may not be filled or refilled more than six months after the date thereof or be refilled more than five times after the date of the prescription unless renewed by the practitioner. --- prescriptions for Schedule IV controlled substances may be written, oral or transmitted by fax. --- partial refills of Schedule IV controlled substance prescriptions are permissible under federal regulations provided that each partial filling is dispensed and recorded in the same manner as a refilling (i.e., date refilled, amount dispensed, initials of dispensing pharmacist, etc.), the total quantity dispensed in all partial fillings does not exceed the total quantity prescribed and no dispensing occurs after six months past the date of issue. --- for C-IV drugs, the auxiliary label "Transfer Warning" is required. --- labels for C-IV drugs must show the date of initial filling. --- labels for C-IV drugs should contain the statement: "Caution: Federal law prohibits the transfer of this drug to any person other than the person for whom it was prescribed." |